中文｜English
ISSN 1001-5256 (Print)
ISSN 2097-3497 (Online)
CN 22-1108/R
Volume 38 Issue 1
Jan.  2022
Turn off MathJax
Article Contents
Article Navigation >  Journal of Clinical Hepatology  > 2022  >  38(1): 97-103

Diagnostic value of transient elastography in the staging of hepatic fibrosis in patients with autoimmune liver disease: A Meta-analysis

DOI: 10.3969/j.issn.1001-5256.2022.01.015
  • 1.

    The Second Clinical Medical College of Beijing University of Chinese Medicine, Beijing 100029, China

  • 2a.

    Department of Spleen-stomach, Liver-gallbladder, Dongfang Hospital, Beijing University of Chinese Medicine, Beijing 100078, China

  • 2b.

    Emergency Department, Dongfang Hospital, Beijing University of Chinese Medicine, Beijing 100078, China

  • Received Date: 2021-05-22
  • Accepted Date: 2021-07-20
  • Published Date: 2022-01-20
    Abstract
  •   Objective  To investigate the value of transient elastography (TE) in the staging of hepatic fibrosis in patients with autoimmune liver disease (ALD).  Methods  PubMed, Embase, the Cochrane Library, CNKI, Wanfang Data, and VIP databases were searched for English and Chinese articles on TE in the staging of hepatic fibrosis in ALD published from January 2000 to January 2021. Two reviewers independently performed data extraction for the articles included, and QUADAS2 was used for quality assessment. The bivariate mixed effects model in Stata 15.0 software was used to perform the Meta-analysis.  Results  A total of 11 articles were included, with 1041 patients in total. In the diagnosis of significant hepatic fibrosis (F≥2), TE had a pooled sensitivity of 0.81 (95% CI: 0.75-0.86), a specificity of 0.87(95%CI 0.79-0.92), and an area under the receiver operating characteristic curve (AUC) of 0.91(95%CI 0.88-0.93); in the diagnosis of advanced hepatic fibrosis (F≥3), TE had a pooled sensitivity of 0.81(95%CI 0.74-0.87), a sensitivity of 0.90(95%CI 0.85-0.93), and an AUC of 0.92(95%CI 0.90-0.94); in the diagnosis of early-stage liver cirrhosis (F4), TE had a pooled sensitivity of 0.87(95%CI 0.74-0.93), a specificity of 0.93(95%CI 0.87-0.97), and an AUC of 0.96(95%CI 0.94-0.97).  Conclusion  TE has a good diagnostic value in evaluating significant liver fibrosis, advanced liver fibrosis, and early-stage liver cirrhosis in patients with ALD, especially with a relatively high diagnostic accuracy for early-stage liver cirrhosis.

     

    • FullText(HTML)
  • loading
    • References(25)
  • [1]
    LYU J, ZHANG H, WANG L. Study progress of the molecular mechanisms and therapies of liver fibrosis[J]. Chin Hosp Pharm J, 2017, 37(18): 1873-1876, 1881. DOI: 10.13286/j.cnki.chinhosppharmacyj.2017.18.24.

    吕舰, 张洪, 王丽. 肝纤维化分子机制及治疗研究进展[J]. 中国医院药学杂志, 2017, 37(18): 1873-1876, 1881. DOI: 10.13286/j.cnki.chinhosppharmacyj.2017.18.24.
    [2]
    XIE AZ, LYU C, SHI QL, et al. Research progress on prevention and treatment of liver fibrosis by traditional Chinese medicine[J]. China Med Herald, 2020, 547(17): 34-37. https://www.cnki.com.cn/Article/CJFDTOTAL-YYCY202017009.htm

    谢爱泽, 吕超, 石清兰, 等. 中医药防治肝纤维化机制的研究进展[J]. 中国医药导报, 2020, 547(17): 34-37. https://www.cnki.com.cn/Article/CJFDTOTAL-YYCY202017009.htm
    [3]
    LIU YY, WANG XF, LI CY, et al. Effects of hepcidin on liver fibrosis by inhibiting hepatocytes apoptosis[J]. J Clin Exp Med, 2021, 20(10): 1013-1017. DOI: 10.3969/j.issn.1671-4695.2021.10.002.

    刘莹莹, 王晓凡, 李长英, 等. 铁调素通过抑制肝细胞凋亡在肝纤维化中的作用机制研究[J]. 临床和实验医学杂志, 2021, 20(10): 1013-1017. DOI: 10.3969/j.issn.1671-4695.2021.10.002.
    [4]
    WANG QX, MA X. Current status and perspectives of autoimmune hepatitis[J]. J Clin Hepatol, 2020, 36(4): 721-723. DOI: 10.3969/j.issn.1001-5256.2020.04.001.

    王绮夏, 马雄. 自身免疫性肝炎的研究现状与展望[J]. 临床肝胆病杂志, 2020, 36(4): 721-723. DOI: 10.3969/j.issn.1001-5256.2020.04.001.
    [5]
    Chinese Foundation for Hepatitis Prevention and Control; Chinese Society of Infectious Disease and Chinese Society of Hepatology, Chinese Medical Association; Liver Disease Committee of Chinese Research Hospital Association. Consensus on clinical application of transient elastography detecting liver fibrosis: A 2018 update[J]. Chin J Hepatol, 2019, 27(3): 182-191. DOI: 10.3760/cma.j.issn.1007-3418.2019.03.004.

    中国肝炎防治基金会, 中华医学会感染病学分会, 中华医学会肝病学分会和中国研究型医院学会肝病专业委员会. 瞬时弹性成像技术诊断肝纤维化专家共识(2018年更新版)[J]. 中华肝脏病杂志, 2019, 27(3): 182-191. DOI: 10.3760/cma.j.issn.1007-3418.2019.03.004.
    [6]
    FLOREANI A, CAZZAGON N, MARTINES D, et al. Performance and utility of transient elastography and noninvasive markers of liver fibrosis in primary biliary cirrhosis[J]. Dig Liver Dis, 2011, 43(11): 887-892. DOI: 10.1016/j.dld.2011.06.011.
    [7]
    WU HM, SHENG L, WANG Q, et al. Performance of transient elastography in assessing liver fibrosis in patients with autoimmune hepatitis-primary biliary cholangitis overlap syndrome[J]. World J Gastroenterol, 2018, 24(6): 737-743. DOI: 10.3748/wjg.v24.i6.737.
    [8]
    XU Q, SHENG L, BAO H, et al. Evaluation of transient elastography in assessing liver fibrosis in patients with autoimmune hepatitis[J]. J Gastroenterol Hepatol, 2017, 32(3): 639-644. DOI: 10.3748/wjg.v24.i6.737.
    [9]
    GUO L, ZHENG L, HU L, et al. Transient elastography (FibroScan) performs better than non-invasive markers in assessing liver fibrosis and cirrhosis in autoimmune hepatitis patients[J]. Med Sci Monit, 2017, 23: 5106-5112. DOI: 10.12659/msm.907300.
    [10]
    CORPECHOT C, GAOUAR F, EL NAGGAR A, et al. Baseline values and changes in liver stiffness measured by transient elastography are associated with severity of fibrosis and outcomes of patients with primary sclerosing cholangitis[J]. Gastroenterology, 2014, 146(4): 970-979; quiz e15-e16. DOI: 10.1053/j.gastro.2013.12.030.
    [11]
    CORPECHOT C, CARRAT F, POUJOL-ROBERT A, et al. Noninvasive elastography-based assessment of liver fibrosis progression and prognosis in primary biliary cirrhosis[J]. Hepatology, 2012, 56(1): 198-208. DOI: 10.1002/hep.25599.
    [12]
    HARTL J, DENZER U, EHLKEN H, et al. Transient elastography in autoimmune hepatitis: Timing determines the impact of inflammation and fibrosis[J]. J Hepatol, 2016, 65(4): 769-775. DOI: 10.1016/j.jhep.2016.05.023.
    [13]
    EHLKEN H, WROBLEWSKI R, CORPECHOT C, et al. Validation of transient elastography and comparison with spleen length measurement for staging of fibrosis and clinical prognosis in primary sclerosing cholangitis[J]. PLoS One, 2016, 11(10): e0164224. DOI: 10.1371/journal.pone.0164224.
    [14]
    CORPECHOT C, EL NAGGAR A, POUJOL-ROBERT A, et al. Assessment of biliary fibrosis by transient elastography in patients with PBC and PSC[J]. Hepatology, 2006, 43(5): 1118-1124. DOI: 10.1002/hep.21151.
    [15]
    GÓMEZ-DOMINGUEZ E, MENDOZA J, GARCíA-BUEY L, et al. Transient elastography to assess hepatic fibrosis in primary biliary cirrhosis[J]. Aliment Pharmacol Ther, 2008, 27(5): 441-447. DOI: 10.1111/j.1365-2036.2007.03585.x.
    [16]
    E ANASTASIOU O, BVCHTER M, A BABA H, et al. Performance and utility of transient elastography and non-invasive markers of liver fiibrosis in patients with autoimmune hepatitis: A single centre experience[J]. Hepat Mon, 2016, 16(11): e40737. DOI: 10.5812/hepatmon.40737.
    [17]
    HASHEMI SA, ALAVIAN SM, GHOLAMI-FESHARAKI M. Assessment of transient elastography (FibroScan) for diagnosis of fibrosis in non-alcoholic fatty liver disease: A systematic review and meta-analysis[J]. Caspian J Intern Med, 2016, 7(4): 242-252.
    [18]
    GENG XX, HUANG RG, LIN JM, et al. Transient elastography in clinical detection of liver cirrhosis: A systematic review and meta-analysis[J]. Saudi J Gastroenterol, 2016, 22(4): 294-303. DOI: 10.4103/1319-3767.187603.
    [19]
    TALWALKAR JA, KURTZ DM, SCHOENLEBER SJ, et al. Ultrasound-based transient elastography for the detection of hepatic fibrosis: systematic review and meta-analysis[J]. Clin Gastroenterol Hepatol, 2007, 5(10): 1214-1220. DOI: 10.1016/j.cgh.2007.07.020.
    [20]
    MATTOS AZ, MATTOS AA. Transient Elastography vs. aspartate aminotransferase to platelet ratio index in hepatitis C: A meta-analysis[J]. Ann Hepatol, 2017, 16(3): 349-357. DOI: 10.5604/16652681.1235477.
    [21]
    SHⅡNA T, NIGHTINGALE KR, PALMERI ML, et al. WFUMB guidelines and recommendations for clinical use of ultrasound elastography: Part 1: basic principles and terminology[J]. Ultrasound Med Biol, 2015, 41(5): 1126-1147. DOI: 10.1016/j.ultrasmedbio.2015.03.009.
    [22]
    CASTÉRA L, FOUCHER J, BERNARD PH, et al. Pitfalls of liver stiffness measurement: A 5-year prospective study of 13, 369 examinations[J]. Hepatology, 2010, 51(3): 828-835. DOI: 10.1002/hep.23425.
    [23]
    ARENA U, LUPSOR PLATON M, STASI C, et al. Liver stiffness is influenced by a standardized meal in patients with chronic hepatitis C virus at different stages of fibrotic evolution[J]. Hepatology, 2013, 58(1): 65-72. DOI: 10.1002/hep.26343.
    [24]
    de LÉDINGHEN V, WONG VW, VERGNIOL J, et al. Diagnosis of liver fibrosis and cirrhosis using liver stiffness measurement: Comparison between M and XL probe of FibroScan®[J]. J Hepatol, 2012, 56(4): 833-839. DOI: 10.1016/j.jhep.2011.10.017.
    [25]
    LUO WP, MA H, WANG Y. Advances in the application of transient elastography in noninvasive diagnosis of liver fibrosis[J]. J Clin Hepatol, 2019, 35(3): 635-639. DOI: 10.3969/j.issn.1001-5256.2019.03.041.

    罗文萍, 马红, 王宇. 瞬时弹性成像在肝纤维化无创诊断中的应用进展[J]. 临床肝胆病杂志, 2019, 35(3): 635-639. DOI: 10.3969/j.issn.1001-5256.2019.03.041.
    • Relative Articles
    • Supplements(0)
    • Cited By
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Figures(9)  / Tables(3)

    Get Citation
    PDF
    XML

    Article Metrics

    Article views (833) PDF downloads(85) Cited by()
    Proportional views
    Related
        

    The first journal specializing in hepatobiliary and pancreatic diseases in China

    Supervisor：Ministry of Education of the People's Republic of China

    Sponsor：Jilin University

    Academic Support: Chinese Society of Hepatology，Chinese Medical Association

    Address: 461 Xinjiang Road, Changchun

    Submit：0431-88782044

    Peer review：0431-88783542

    Email：lcgdb@vip.163.com

    About Journal

    Submission Guideline

    Journal Online

    Hepatobiliary College

    Guidelines

    YesterdayIP[]YesterdayPV[]TodayIP[]TodayPV[]Online[]

    Website Design © 2020 Editorial Board of Journal of Clinical Hepatology 吉ICP备10000617号-1 Supported by: Beijing Renhe Information Technology Co. Ltd  

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return